A powerful institutional cluster formed in BMY during Q2 2026, with 20 buyers accumulating $2.46B net against 8 sellers reducing by $680M. The buying is dominated by Norges Bank's massive $2.12B new position, alongside significant adds from Fidelity and T. Rowe Price, while Dodge & Cox and Capital International were notable sellers. This cluster aligns with the company's strong Q2 earnings beat and raised guidance reported 18 days prior, suggesting institutions are positioning for sustained Growth Portfolio momentum and upward earnings revisions. The absence of insider buying weakens the conviction slightly, but the scale and breadth of institutional accumulation is a strong bullish signal for the pharmaceutical giant's turnaround story.
BMY drugs
BMY drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 17 $64.63entry
- T+1 · 3mo ago +2.20%α +2.87% · $66.05
- T+5 · 3mo ago +4.10%α +5.29% · $67.28
- T+20 · 2mo ago −1.39%α +0.58% · $63.73
- T+60 · 7d ago −2.83%α +0.11% · $62.80
How similar events traded
Executive Summary
A powerful institutional cluster formed in BMY during Q2 2026, with 20 buyers accumulating $2.46B net against 8 sellers reducing by $680M. The buying is dominated by Norges Bank's massive $2.12B new position, alongside significant adds from Fidelity and T. Rowe Price, while Dodge & Cox and Capital International were notable sellers. This cluster aligns with the company's strong Q2 earnings beat and raised guidance reported 18 days prior, suggesting institutions are positioning for sustained Growth Portfolio momentum and upward earnings revisions. The absence of insider buying weakens the conviction slightly, but the scale and breadth of institutional accumulation is a strong bullish signal for the pharmaceutical giant's turnaround story.
Key Financial Metrics
Institutional Positions
Net institutional flow: $2.5B
▲ Buyers (20)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Norges Bank | NEW | Not reported | $2.1B | $2.1B |
| Fidelity | ADD | +52.7% | $938.8M | $291.6M |
| T. Rowe Price | DOUBLED | +209.3% | $1.8M | $1.2M |
▼ Sellers (8)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Dodge & Cox | NEAR_EXIT | -99.1% | $280.4M | -$277.9M |
| Capital International Investors | TRIM | -29.9% | $511.2M | -$170.4M |
| Renaissance Technologies | EXIT | -100% | $59.3M | -$59.3M |
Key Facts
- 20 institutional buyers vs 8 sellers in Q2 2026
- Net institutional accumulation of $2.46B
- Norges Bank initiated a $2.12B new position (36.87M shares)
- Fidelity added $291.6M (+52.7% position increase)
- T. Rowe Price doubled its position (+209.3%)
- Dodge & Cox nearly exited ($277.9M sold, -99.1%)
- Renaissance Technologies and Bridgewater fully exited
- Cluster follows Q2 2026 earnings beat (EPS $2.04 vs $1.60 est) and raised full-year guidance
- No open-market insider buying during the window (institutions-only signal)
Financial Impact
Net institutional buying of $2.46B across 20 funds, with total buying value of $3.15B and total selling value of $680M
Risk Factors
- No insider buying to corroborate the institutional thesis
- Dodge & Cox's near-exit and Capital International's trim suggest some long-term holders are skeptical
- 13F data is 45+ days stale; positions may have been adjusted since quarter-end
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BMY-2026-Q2 |
Track record
9 reports on BMY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $62.14 to $62.14 · 0.00% −2.37% vs SPY
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $61.39 to $62.48 ▲ +1.78% +3.55% vs SPY
- Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $61.48 to $61.61 ▲ +0.21% −0.50% vs SPY
- Oct 5, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
- Aug 17, 202613w ago Institutional Cluster Bullish 6/10 Viewing Entry $64.63 to $66.05 ▲ +2.20% +2.87% vs SPY
- Aug 5, 202614w ago ANALYST-UPGRADE Bullish 4/10 Entry $63.63 to $64.15 ▲ +0.82% +0.98% vs SPY
- Jul 30, 202615w ago 8-K Bullish 7/10 Entry $64.86 to $65.31 ▲ +0.69% −0.01% vs SPY
- Mar 25, 202633w ago DEFA14A Neutral 3/10 Entry $59.39 to $58.47 ▼ −1.55% +0.13% vs SPY
- Feb 26, 202637w ago Court Ruling Neutral 3/10 Entry $62.37 to $62.34 ▼ −0.05% −0.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers